BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29470826)

  • 21. Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up.
    Marongiu A; Nuvoli S; De Vito A; Vargiu S; Spanu A; Madeddu G
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis.
    Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Kim YN; Kim H; Kim SW; Chung JH
    Br J Surg; 2018 Feb; 105(3):270-278. PubMed ID: 29405275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
    Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
    Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
    Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
    PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
    Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
    Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Minimal Extra-Thyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-analysis.
    Diker-Cohen T; Hirsch D; Shimon I; Bachar G; Akirov A; Duskin-Bitan H; Robenshtok E
    J Clin Endocrinol Metab; 2018 Mar; ():. PubMed ID: 29506045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy.
    Song E; Kim WW; Jeon MJ; Sung TY; Song DE; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Lee YM; Kim WG
    Ann Surg Oncol; 2019 Dec; 26(13):4466-4471. PubMed ID: 31471840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soft tissue invasion of papillary thyroid carcinoma.
    Lin JD; Hsueh C; Chao TC
    Clin Exp Metastasis; 2016 Aug; 33(6):601-8. PubMed ID: 27154220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma.
    Hu D; Zhou J; He W; Peng J; Cao Y; Ren H; Mao Y; Dou Y; Xiong W; Xiao Q; Su X
    World J Surg Oncol; 2018 Feb; 16(1):30. PubMed ID: 29439716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal extrathyroid extension in papillary micro carcinoma of the thyroid is an independent risk factor for relapse through lymph node and distant metastases.
    Seifert R; Schäfers MA; Heitplatz B; Kerschke L; Riemann B; Noto B
    J Nucl Med; 2021 Mar; 62(12):1702-9. PubMed ID: 33771902
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary thyroid microcarcinoma with minimal extrathyroidal extension. Is its course so indolent that it requires a less aggressive treatment?
    Ruiz Pardo J; Ríos Zambudio A; Rodríguez González JM; Paredes Quiles M; Soriano Giménez V; Oviedo Ramírez MI; Hernández Martínez AM; Parrilla Paricio P
    Rev Clin Esp; 2021 Mar; 221(3):131-138. PubMed ID: 32216965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
    Leboulleux S; Rubino C; Baudin E; Caillou B; Hartl DM; Bidart JM; Travagli JP; Schlumberger M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5723-9. PubMed ID: 16030160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes.
    Watutantrige-Fernando S; Vianello F; Barollo S; Bertazza L; Galuppini F; Cavedon E; Censi S; Benna C; Ide EC; Parisi A; Nacamulli D; Iacobone M; Pennelli G; Mian C
    Thyroid; 2018 Jan; 28(1):96-103. PubMed ID: 29179638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.
    Howell GM; Carty SE; Armstrong MJ; Lebeau SO; Hodak SP; Coyne C; Stang MT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
    Ann Surg Oncol; 2011 Dec; 18(13):3566-71. PubMed ID: 21594703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
    Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
    Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients.
    Suh YJ; Kwon H; Kim SJ; Choi JY; Lee KE; Park YJ; Park DJ; Youn YK
    Ann Surg Oncol; 2015 Oct; 22(11):3543-9. PubMed ID: 25743326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma?
    Capezzone M; Secchi C; Fralassi N; Cantara S; Brilli L; Ciuoli C; Pilli T; Maino F; Forleo R; Pacini F; Castagna MG
    J Endocrinol Invest; 2019 Oct; 42(10):1205-1213. PubMed ID: 30927240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.